The President and Chief Executive Officer of Neumora Therapeutics is Dr. Joshua Pinto. He initially joined the organization as its Chief Financial Officer, where he played a pivotal role in driving corporate business development, establishing key neuroscience pipeline licensing agreements, and executing critical fundraising strategies before transitioning into the top executive leadership role to steer the company through its clinical development phases and organizational restructuring.